It is important to educate and bring awareness to childhood lymphoma, its symptoms, treatment options, and the need for ...

While Yawnick's symptoms were a close match, they didn't subside with the prescribed medication ... Yawnick underwent multiple biopsies and a PET scan before learning he had primary mediastinal B-cell ...

July 22, 2024 — The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for ...

5 Here, we describe a case of aggressive CAR+ T-cell lymphoma and investigate its lymphomagenesis. A 60-year-old man received the diagnosis of primary central nervous system lymphoma (PCNSL ...

chemo-immunotherapy followed by a Autologous stem cell transplant Chemoimmunotherapy with or without Antibody Drug Conjugate ...

Not only can inexplicable weight loss and night sweat be a nuisance but they can also be a grave indicator of seeking medical ...

Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous ...

When it was time to decide where he wanted to work, Dalton Cummins tells PEOPLE that going back to the hospital where he beat ...

Topical/skin directed therapies are best for early-stage disease or in combination with systemic therapies in advanced disease, according to Dr Arron Mangold.

A new study finds that one form -- CAR-T therapy -- can be successfully and safely delivered in an outpatient setting TUESDAY ...

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company ...

Based on ECHO Phase III trial which demonstrated CALQUENCE combination reduced risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy Submission to be reviewed ...